home / stock / czo:cc / czo:cc news

CZO:CC News and Press, Ceapro Inc. From 02/15/24

Stock Information
Company Name: Ceapro Inc.
Stock Symbol: CZO:CC
Market: TSXVC
Website: ceapro.com
Menu
CZO:CC CZO:CC Quote CZO:CC Short CZO:CC News CZO:CC Articles CZO:CC Message Board
Get CZO:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
CZO:CC - Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

EDMONTON, Alberta, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSXV: CZO) (OTCQX: CRPOF) (“ Ceapro ” or the “ Company ”) is pleased to announce that it has mailed and filed a management information circular dated February 9, 2024 and related meeting material...
CZO:CC - Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

Aeterna Zentaris Board recommends shareholders vote FOR all resolutions, to create a diversified biopharmaceutical company with a compelling value proposition More information and materials available at www.AEZSmerger.com Shareholders with questions or who ...

CZO:CC - Canadian Investment Regulatory Organization Trade Resumption - CZO

Canadian Investment Regulatory Organization Trade Resumption - CZO Canada NewsWire VANCOUVER, BC , Dec. 14, 2023 /CNW/ - Trading resumes in: Company: Ceapro Inc. TSX-Venture Symbol: CZO All Issues: Yes Resumption (ET): 11:00 AM CIRO can make a...

CZO:CC - Canadian Investment Regulatory Organization Trading Halt - CZO

Canadian Investment Regulatory Organization Trading Halt - CZO Canada NewsWire VANCOUVER, BC , Dec. 14, 2023 /CNW/ - The following issues have been halted by CIRO Company: Ceapro Inc. TSX-Venture Symbol: CZO All Issues: Yes Reason: Pending...
CZO:CC - Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

TORONTO and EDMONTON, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSXV: CZO) (OTCQX: CRPOF) (“ Ceapro ”), two innovative biopharmaceutical development companies, today announced that they h...

CZO:CC - Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a Study Assessing Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

– Study being led by Dr. Jean-Claude Tardif at the Montreal Heart Institute – No adverse reactions observed, and study can continue as planned EDMONTON, Alberta, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro”...

CZO:CC - Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights

– Product development focused on the production of powder formulations of oat beta glucan and avenanthramides for cosmeceuticals market – Technology development focused on the PGX pilot scale units – Q3 2023 sales of $2,619,000 vs $3,845,000 in Q3 2022 ;...
CZO:CC - Expected Canadian Company Earnings on Wednesday, November 29th, 2023

MediaValet Inc. (MVP:CA) is expected to report for Q3 2023 Akumin Inc. (AKU:CA) is expected to report for Q3 2023 Monument Mining Limited (MMY:CA) is expected to report for quarter end 2023-09-30 Skylight Health Group Inc. (SLHG.H:CA) is expected to report for Q3 2023 Noble Iron I...

CZO:CC - Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

Study being led by Dr. Jean-Claude Tardif at the Montreal Heart Institute Screening of healthy subjects is now underway Phase 1-2a study to provide valuable insights into the safety and activity of avenanthramides in managing conditions related to inflammation EDMONTON, Albe...

CZO:CC - Expected Canadian Company Earnings on Wednesday, November 22nd, 2023

Platinum Group Metals Ltd. (PTM:CA) is expected to report for quarter end 2023-08-31 C-COM Satellite Systems Inc. (CMI:CA) is expected to report for Q1 2024 Skylight Health Group Inc. (SLHG.H:CA) is expected to report for Q3 2023 Contagious Gaming Inc. (CNS:CA) is expected to report f...
Previous 10 Next 10